Personalis Gross Margin 2018-2023 | PSNL
Current and historical gross margin for Personalis (PSNL) over the last 10 years. The current gross profit margin for Personalis as of December 31, 2023 is %.
| Personalis Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2023-12-31 |
$0.07B |
$0.02B |
24.32% |
| 2023-09-30 |
$0.07B |
$0.02B |
21.13% |
| 2023-06-30 |
$0.07B |
$0.01B |
20.59% |
| 2023-03-31 |
$0.07B |
$0.01B |
18.84% |
| 2022-12-31 |
$0.07B |
$0.01B |
18.46% |
| 2022-09-30 |
$0.07B |
$0.02B |
26.09% |
| 2022-06-30 |
$0.08B |
$0.02B |
31.58% |
| 2022-03-31 |
$0.08B |
$0.03B |
35.00% |
| 2021-12-31 |
$0.09B |
$0.03B |
36.05% |
| 2021-09-30 |
$0.09B |
$0.03B |
34.12% |
| 2021-06-30 |
$0.08B |
$0.03B |
31.33% |
| 2021-03-31 |
$0.08B |
$0.02B |
28.75% |
| 2020-12-31 |
$0.08B |
$0.02B |
25.64% |
| 2020-09-30 |
$0.08B |
$0.02B |
27.63% |
| 2020-06-30 |
$0.07B |
$0.02B |
30.14% |
| 2020-03-31 |
$0.07B |
$0.02B |
32.86% |
| 2019-12-31 |
$0.07B |
$0.02B |
35.38% |
| 2019-06-30 |
$0.04B |
$0.01B |
33.33% |
| 2019-03-31 |
$0.04B |
$0.01B |
28.57% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.063B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
